- Trials with a EudraCT protocol (147)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: VIALLATE J. Appréciation clinique du rôle de l'Arginine sur la nutrition et la croissance (Clinical estimate of the part played by arginine on nutrition and growth). Rev. Pédiatrie, VIII, 7, 419-423, 1972 |
Active substance: ARGININE DIHYDRATE |
Study summary document link (including results): Arginine Option1.xls |
View full study record |
Document reference: 47170 |
Study title: An uncontrolled study of the safety and efficacy of ceftazidime/arginine in children with serious or moderately serious bacterial infections. |
Active substance: CEFTAZIDIME |
Study summary document link (including results): Study CART03 Ceftazidime.xls |
View full study record |
Document reference: 47113 |
Study title: Figueras−Nadal−C et al. Effectiveness and tolerability of ibuprofen−arginine versus paracetamol in children with fever of likely infectious origin. {ACTA−PAEDIATR− INT−J−PAEDIATR}, 2002, Vol/Iss/Pg. 91/4 (383−390) |
Active substance: CHLORPHENIRAMINE + DEXTROMETHORPHAN + PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 23985 |
Study title: A randomized, parallel, single dose, double-blind, double-dummy multicentre study to assess the antipyretic activity and tolerability of ibuprofen-arginine drops, in comparison to paracetamol in the treatment of likely infectious pediatric fever. |
Active substance: CLOPERASTINE |
Study summary document link (including results): |
View full study record |
Document reference: 24410 |
Study title: AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. IN C/Ecija, 101,28230 Las Rozas, Spain. SO Anales Espanoles de Pediatria {AN-ESP-PEDIATR}, 1993, Vol/Iss/Pg. 38 /6 (509-515), ISSN: 0302-4342. YR 1993.AN 1993195892 19930101. TI Controlled trial with clonidine, arginine asparate, ornithine, alpha- ketoglutarate and cyproheptadine as growth stimulants in healthy children of short stature. AU Herranz-Jordan-B, Moreno-Romero-F, Cardesa-Garcia-J-J, Santos- Hurtado-I, Aparicio-Palomino-A, Requena-Guerrero-F. I... |
Active substance: CYPROHEPTADINE |
Study summary document link (including results): |
View full study record |
Document reference: 25259 |
Study title: Ghigo E et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry. 1994 Nov 15;36(10):689-95Ghigo E et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry. 1994 Nov 15;36(10):689-95 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35201 |
Study title: Ghigo E et al. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf). 1990 Jun;32(6):763-7Ghigo E et al. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf). 1990 Jun;32(6):763-7 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35213 |
Study title: Guzzaloni G, Grugni G, Morabito F. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Minerva Endocrinol. 1998 Dec;23(4):99-104Guzzaloni G, Grugni G, Morabito F. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Minerva Endocrinol. 1998 Dec;23(4):99-104 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35192 |
Study title: Procopio M et al. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Int J Obes Relat Metab Disord. 1995 Feb;19(2):108-12Procopio M et al. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Int J Obes Relat Metab Disord. 1995 Feb;19(2):108-12 |
Active substance: PYRIDOSTIGMINE |
Study summary document link (including results): |
View full study record |
Document reference: 35199 |
Study title: Figueras−Nadal−C et al. Effectiveness and tolerability of ibuprofen−arginine versus paracetamol in children with fever of likely infectious origin. {ACTA−PAEDIATR− INT−J−PAEDIATR}, 2002, Vol/Iss/Pg. 91/4 (383−390)Figueras−Nadal−C et al. Effectiveness and tolerability of ibuprofen−arginine versus paracetamol in children with fever of likely infectious origin. {ACTA−PAEDIATR− INT−J−PAEDIATR}, 2002, Vol/Iss/Pg. 91/4 (383−390) |
Active substance: PARACETAMOL AND DIPHENHYDRAMINE |
Study summary document link (including results): |
View full study record |
Document reference: 33383 |
Study title: Figueras−Nadal−C et al. Effectiveness and tolerability of ibuprofen−arginine versus paracetamol in children with fever of likely infectious origin. {ACTA−PAEDIATR− INT−J−PAEDIATR}, 2002, Vol/Iss/Pg. 91/4 (383−390) |
Active substance: CODEINE_AND_PARACETAMOL |
Study summary document link (including results): |
View full study record |
Document reference: 24514 |